Professional Documents
Culture Documents
Staphylococci
‘BUNCH OF GRAPES
Gram-positive Cocci
• Coccus ‘ Spherical shape’.
2
STAPHYLOCOCCUS
3
4
PROPERTIES
Characteristics:
• Non-spore forming.
5
PROPERTIES
Main habitat:
• Exist as a normal flora on skin and mucosal surfaces of human.
• S. aureus is also found in the vagina of approximately 5% of women.
• All over hospitals.
Transmission:
• Staphylococcus aureus is always spread by physical contact, not through the air.
• Staphylococcus aureus can spread directly from the pus of an infection like boils or
abscesses through skin-to-skin contact.
• Through indirect contact with contaminated objects such as sheets, towels, sport equipment.
• Presence of foreign body (suture, catheter).
• Unnecessary antibiotic use for years.
• Staphylococcus aureus can survive on dry surfaces for up to several months.
6
VIRULENCE FACTORS
1) Protein A: This protein has sites that bind immunoglobulin IgG, preventing
opsonization and phagocytosis.
4) Hemolysins: β-hemolysis (complete lysis of red blood cells) on an agar plate which
appears as a yellow golden pigment on sheep blood agar. Hemolysins destroy RBCs,
macrophages, and platelets.
7
VIRULENCE FACTORS
8) lipases: Degrades fats and oil on the surface of our body. This degradation
facilitates S. aureus’ colonization of glands.
9) Protease: Destroys tissue proteins.
8
CLINICAL DISEASES
11
CLINICAL DISEASES
1) Local infection:
D) Wound infections:
Carbuncles Furuncle
14
CLINICAL DISEASES
2)Systemic diseases:
A.Pneumonia:
• S. aureus pneumonia usually follows a viral influenza (flu) upper respiratory illness, with
onset of fever, chills, rapid destruction of lung, resulting in cavitaions (holes in the lung),
and pus.
• In many hospitals, S. aureus is the most common cause of nosocomial pneumonia.
15
CLINICAL DISEASES
Staphylococcus aureus pneumonia
16
CLINICAL DISEASES
C. Osteomyelitis: Osteomyelitis
• This is a bone infection that usually
occurs in children <12 years of age.
17
CLINICAL DISEASES
D. Arthritis:
18
CLINICAL DISEASES
E. Endocarditis:
• This is a destructive infection of the heart valves.
• A sudden onset of high fever, chills, and myalgia.
• Intravenous drug (IV) users develop endocarditis.
19
MRSA FACT SHEET
• MRSA is Methicillin-Resistant
Staphylococcus aureus.
• More than 90% of S. aureus contain
plasmid that encode β-lactamase
(penicillinase) which provide resistance
to antibiotics such as penicillinase-
resistant penicillins (methicillin,
nafcillin, oxacillin, etc.).
• MRSA is a dangerous type of S. aureus
causes skin and other infections.
• MRSA tend to develop in the hospital,
where broad spectrum antibiotics are
used.
• MRSA is spread by the hand contact with
another infected patient, sharing personal
items (towels, razors, etc.), touching
surface or items contaminated with
MRSA. 20
LABORATORY DIAGNOSIS
• Infected wound (either a small biopsy of skin or pus taken with a swab) or of
the blood must be obtained to grow the bacteria in the microbiology
laboratory. Once the Staph is growing, the organism is tested to determine
which antibiotics will be effective for treating the infection.
21
LABORATORY DIAGNOSIS
25
PREVENTION
26
27
PROPERTIES
Characteristics:
28
VIRULENCE FACTORS
• Polysaccharide Capsule: adhere to a variety of prosthetic devices such as
prosthetic joints, prosthetic heart valves, and peritoneal dialysis catheters.
• Highly resistant to antibiotics.
Clinical diseases
• S. epidermidis enters the blood stream causing bacteremia.
3) Metabolic:
• Catalase test-positive.
• Coagulase test-negative.
4) Antibiotic test:
• Sensitive to novobiocin antibiotic
CLINICAL DISEASES
33
LABORATORY DIAGNOSIS
1) Gram stain:
• Gram positive cocci in clusters.
2) Culture:
• Gamma-hemolytic.
3) Metabolic:
• Catalase test-positive.
• Coagulase test-negative.
Novobiocin-resistant
4) Antibiotic test:
• Resistant to novobiocin antibiotic
34
Gram Positive Cocci
GPC
Catalase-test
Staphylococci
35
Coagulase-test
Methicillin Novobiocin
R S R
36
37